Skip to content

BioLife Solutions BLFS Operating Lease Liabilities (Current)

Operating Lease Liabilities (Current) at other companies

Danaher logo
DanaherDHR
$1.2B+9.1%
LeMaitre Vascular logo
LeMaitre VascularLMAT
$3.45M+30.8%
TEC
Bio-TechneTECH
$14.18M+0.9%
CryoPort, Inc. logo
CryoPort, Inc.CYRX
$3.64M-0.5%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$36.2M-12.3%
Labcorp Holdings logo
Labcorp HoldingsLH
$183.2M+0.2%

Other financials

Income statement

See full
Revenue$27.5M+24.7%
Gross profit$17.5M+18.2%
Operating income$27.0K+105%
Net income$1.2M+365%
EPS (diluted)$0.02

Balance sheet

See full
Cash & equivalents$22.8M-65.9%
Total debt$17.4M-35.6%
Total equity$372.2M+5.6%
Total assets$400.9M+1.5%

Cash flow

See full
Operating cash flow-$491.0K-128%
CapEx$167.0K-4.6%
Free cash flow-$658.0K-142%

Valuation

See full
Market cap$1.25B+23.8%
Enterprise value$1.24B+28.3%
P/S12.5×-0.4×

Profitability

See full
Gross margin66.9%
Operating margin-16.7%
Net margin-68.7%
FCF margin-15.9%+18.7pp

Returns & leverage

See full
Return on equity-14.5%-4.7pp
Debt / equity0.0×
Current ratio7.3×+2.6×

Where this comes from

Reported directly by BioLife Solutions in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.

The official record: BioLife Solutions’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioLife Solutions's operating lease liabilities (current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BioLife Solutions's operating lease liabilities (current)?
BioLife Solutions (BLFS) reported operating lease liabilities (current) of $2.32M in Q1 2026.
How has BioLife Solutions's operating lease liabilities (current) changed year-over-year?
BioLife Solutions's operating lease liabilities (current) increased by 26.2% year-over-year, from $1.84M to $2.32M.
What is the long-term trend for BioLife Solutions's operating lease liabilities (current)?
Over 5 years (2020 to 2025), BioLife Solutions's operating lease liabilities (current) has grown at a 15.2% compound annual growth rate (CAGR), from $1.11M to $2.24M.
What does operating lease liabilities (current) mean?
The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.